20年来代谢/腹腔外科手术中的种族和性别差异:一项队列研究
Benjamin Grobman1,2, Liyun He2,3, Zhou Lan1,4
1From the Harvard Medical School, Boston, MA.
概括
代谢和减肥手术 (MBS) 进展的种族差异仍然存在,特别是在黑人患者中,尽管随着时间的推移而缩小. 男人不太可能讨论或接受MBS,这一差距正在扩大.
科学领域:
- 医学研究 医学研究
- 公共卫生 公共卫生
- 外科手术的结果
背景情况:
- 肥胖是一个重要的公共卫生问题.
- 代谢和减肥手术 (MBS) 是最有效的长期肥胖治疗方法.
研究的目的:
- 分析20年来代谢和减肥手术 (MBS) 讨论和种族和性别的吸收趋势.
- 为了确定MBS讨论和进展在2级或更高肥胖症患者中的差异.
主要方法:
- 使用电子健康记录 (2000-2020) 的回顾性队列研究.
- 自然语言处理算法用于识别MBS讨论.
- 多变量后勤回归用于评估社会人口统计因素和MBS讨论和接收的时间.
主要成果:
- 分析了超过122,000名患者;9.1%的人讨论了MBS,12.2%的人进行了手术.
- 与非黑人患者相比,黑人患者进展到MBS的可能性较低 (8.4%对12.6%),尽管差异缩小了.
- 与女性相比,男性讨论 (8.1%与9.6%) 和接受MBS (7.6%与14.6%) 的可能性较低,这一差距越来越大.
结论:
- 干预措施应针对从MBS讨论到手术的进展,以减少种族差异.
- 需要制定策略,在整个护理过程中提高男性对MBS的接受率.
相关概念视频
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...


